SCHEMBL3715538

SCHEMBL3715538

O=C(OCc1ccccc1)N1CCCC(N2CCNC2=O)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
CYP2C19 P33261 1/20 0.48
JAK2 O60674 2/20 0.46
JAK1 P23458 2/20 0.46
TYK2 P29597 2/20 0.46
JAK3 P52333 2/20 0.46
USP30 Q70CQ3 1/20 0.46
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
FKBP1A P62942 2/20 0.45
TMEM97 Q5BJF2 2/20 0.45
SIGMAR1 Q99720 2/20 0.45
HTR1A P08908 1/20 0.45
ADRA2C P18825 1/20 0.45
HRH2 P25021 1/20 0.45
HRH1 P35367 1/20 0.45
HRH3 Q9Y5N1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20986826 0.94 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9ACYP2C19JAK2
SCHEMBL23164394 0.90 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL2858459 0.86 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL4512387 0.83 SMN1; SMN2 (0.51) SMN1; SMN2NPC1RAB9ACYP2C19JAK2
SCHEMBL12815027 0.82 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9ACYP2C19JAK2
SCHEMBL2857739 0.82 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL18149461 0.81 SMN1; SMN2 (0.51) SMN1; SMN2NPC1RAB9ACYP2C19USP30
SCHEMBL18159775 0.81 SMN1; SMN2 (0.51) SMN1; SMN2NPC1RAB9ACYP2C19USP30
SCHEMBL18159771 0.81 SMN1; SMN2 (0.51) SMN1; SMN2NPC1RAB9ACYP2C19USP30
SCHEMBL20986848 0.81 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9ACYP2C19JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010091721-A1 3 -SUBSTITUTED 1-ARYLSULFONYLPIPERIDINE DERIVATIVES FOR THE TREATMENT OF PAIN GLAXO GROUP LIMITED (GB) 2010-08-19 WO disclosed